No offense. When you consider the benefits of Covid immunity on a mass scale, both in terms of the economy and public confidence, paying a few euros more for each dose to guarantee maximum access is neither here nor there. When on a winning streak, you should make the most of it. The European Medicines Agency put the number at 60 percent. The problem with the trials, unless you run the trials head-to-head, you dont really know whether a 95 percent figure on trial and 62 percent in another trial mean the same thing, he said.
The European Medicines Agency puts numbers in a 70 percent
( z0 put :ARG0 ( z1 organization :name ( z2 name :op "European" :op "Medicines" :op "Agency" ) ) :ARG1 ( z3 number ) :ARG2 ( z4 percentage-entity :value 70 ) )
(z0 / put-01
    :ARG0 (z1 / organization
              :name (z2 / name
                        :op1 "European"
                        :op2 "Medicines"
                        :op3 "Agency"))
    :ARG1 (z3 / number)
    :ARG2 (z4 / percentage-entity
              :value 70))
The European Medicines Agency puts numbers in a 70 percent
z2 :op1 2
z2 :op2 3
z1 :name z2
z2 :op3 1
z0 :ARG0 z1
z0 :ARG1 z3
z4 :value 0
z0 :ARG2 z4